Joerg Neermann insider trades: Immunic (IMUX) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Joerg reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 5, 2025 | IMUX | ↑ Buy | 100,000 | $0.77 | $77K | Direct | Jun 5, 2025 (0d) |
| Dec 14, 2022 | IMUX | ↑ Buy | 82,000 | $1.25 | $103K | Direct | Dec 15, 2022 (1d) |
| Nov 23, 2022 | IMUX | ↑ Buy | 18,000 | $1.39 | $25K | Direct | Nov 25, 2022 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Joerg Neermann's insider trades
Joerg Neermann is a director at Immunic (IMUX). Since Nov 23, 2022, Joerg has reported 3 open-market purchases worth $204K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (10 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IMUX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.